Age-related decline in the microstructural integrity of white matter in children with early- and continuously-treated PKU: A DTI study of the corpus callosum

Molecular Genetics and Metabolism

Volumn 99, Issue SUPPL., 2010, Pages

  White, Desiree A ^a   Connor, Lisa Tabor ^b   Nardos, Binyam ^c   Shimony, Joshua S ^d   Archer, Rebecca ^a   Snyder, Abraham Z ^d   Moinuddin, Asif ^d   Grange, Dorothy K ^b   Steiner, Robert D ^e   McKinstry, Robert C ^d  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d ST LOUIS CHILDREN S HOSPITAL   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Children; Corpus callosum; Diffusion tensor imaging; Phenylketonuria; White matter

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; BRAIN DEVELOPMENT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; HUMAN; OUTCOME VARIABLE; PATHOLOGY; PHENYLKETONURIA; PRIORITY JOURNAL; SCHOOL CHILD; WHITE MATTER;

EID: 72249092405     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2009.09.016     Document Type: Article

References (40)

1. Scriver C.R. The PAH gene, phenylketonuria, and a paradigm shift. Hum. Mutat. 28 (2007) 831-845
2. Scriver C.R., and Kaufman S. Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Scriver C.R., Beaudet A.L., Sly W., Valle D., Childs B., and Vogelstein B. (Eds). The Metabolic and Molecular Basis of Inherited Disease (2001), McGraw-Hill, New York 1667-1724
3. DeRoche K., and Welsh M. Twenty-five years of research on neurocognitive outcomes in early-treated phenylketonuria: intelligence and executive function. Dev. Neuropsychol. 33 (2008) 474-504
4. Christ S.E., Huijbregts S.C.J., de Sonnerville L.M.J., and White D.A. Executive function in early-treated phenylketonuria: profile and underlying mechanisms. Mol. Genet. Metab. 99 (2009) S22-S32
5. Anderson P.J., Wood S.J., Francis D.E., Coleman L., Warwick L., Casanelia S., Anderson V.A., and Boneh A. Neuropsychological functioning in children with early-treated phenylketonuria: impact of white matter abnormalities. Dev. Med. Child Neurol. 46 (2004) 230-238
6. Bick U., Ullrich K., Stober U., Moller H., Schuierer G., Ludolph A.C., Oberwittler C., Weglage J., and Wendel U. White matter abnormalities in patients with treated hyperphenylalaninemia: magnetic resonance relaxometry and proton spectroscopy findings. Eur. J. Pediatr. 152 (1993) 1012-1020
7. Cleary M.A., Walter J.H., Wraith J.E., Jenkins J.P., Alani S.M., Tyler K., and Whittle D. Magnetic resonance imaging of the brain in phenylketonuria. Lancet 344 (1994) 87-90
8. Cleary M.A., Walter J.H., Wraith J.E., White F., Tyler K., and Jenkins P.R. Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change. J. Pediatr. 127 (1995) 251-255
9. Dezortova M., Jajek M., Tintera J., Hejcmanova L., and Sykova E. MR in phenylketonuria-related brain lesions. Acta Radiol. 42 (2001) 459-466
10. Kono K., Okano Y., Nakayama K., Hase Y., Minamkiawa S., Ozawa N., Yokote H., and Inoue Y. Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter. Radiology 236 (2005) 630-636
11. 1H MRS) study. J. Inherit. Metab. Dis. 30 (2007) 209-216
12. R. Manara, A.P. Burlina, V. Citton, M. Ermani, F. Vespignani, C. Carollo, A.B. Burlina, Brain MRI diffusion-weighted imaing in patients with classical phenylketonuria, Neuroradiology 2009 (EPub ahead of print).
13. Phillips M.D., McGraw P., Lowe M.J., Mathews V.P., and Hainline B.E. Diffusion-weighted imaging of white matter abnormalities in patient with phenylketonuria. Am. J. Neuroradiol. 22 (2001) 1583-1586
14. Scarabino T., Popolizio T., Tosetti M., Montanaro D., Giannatempo G.M., Terlizzi R., Pollice S., Maiorana A., Maggialetti N., Carriero A., Leuzzi V., and Salvolini U. Phenylketonuria: white matter changes assessed by 3.0-T magnetic resonance (MR) imaging, MR spectroscopy and MR diffusion. Radiol. Med. 114 (2009) 461-474
15. Vermathen P., Robert-Tissot L., Pietz J., Lutz T., Boesch C., and Kreis R. Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging. Magn. Reson. Med. 58 (2007) 1145-1156
16. Diamond A. Evidence for the importance of dopamine for prefrontal functions early in life. In: Roberts A., and Robbins T. (Eds). The Prefrontal Cortex: Executive and Cognitive Functions (1998), Oxford University Press, New York 144-164
17. Anderson P.J., Wood S.J., Francis D.E., Coleman L., Anderson V., and Boneh A. Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?. Dev. Neuropsychol. 32 (2007) 645-668
18. Pérez-Dueñas B., Pujol J., Soriano-Mas C., Ortiz H., Artuch R., Vilaseca M.A., and Campistol J. Global and regional volume changes in the brains of patients with phenylketonuria. Neurology 66 (2006) 1074-1078
19. Pfaendner N.H., Reuner G., Pietz J., Jost G., Rating D., Magnotta V.A., Mohr A., Kress B., Sartor K., and Hahnel S. MR imaging-based volumetry in patients with early-treated phenylketonuria. Am. J. Neuroradiol. 26 (2005) 1681-1685
20. Engelbrecht V., Scherer A., Rassek M., Witsack H.J., and Modder U. Diffusion-weighted MR imaging in the brain in children: findings in the normal brain and in the brain with white matter diseases. Radiology 222 (2002) 410-418
21. R.N. Sener, Diffusion magnetic resonance imaging patterns in metabolic and toxic brain disorders, Acta Radiol. 45 (2004) 561-570.
22. Ding X., Fiehler J., Kohlschutter B., Wittkugel O., Grzyska U., Zeumer H., and Ullrich K. MRI abnormalities in normal-appearing brain tissue of treated adult PKU patients. J. Magn. Reson. Imaging 27 (2008) 998-1004
23. Sener R.N. Phenylketonuria: diffusion magnetic resonance imaging and proton magnetic resonance spectroscopy. J. Comput. Assist. Tomogr. 27 (2003) 541-543
24. Peng S.S., Tseng W.Y., Chien Y.H., Hwu W.L., and Liu H.M. Diffusion tensor images in children with early-treated, chronic, malignant phenylketonuric: correlation with intelligence assessment. Am. J. Neuroradiol. 25 (2004) 1569-1574
25. Hofer S., and Frahm J. Topography of the human corpus callosum revisited-comprehensive fiber tractography using diffusion tensor magnetic resonance imaging. Neuroimage 32 (2006) 989-994
26. Miller J.H., McKinstry R.C., Philip J.V., Mukherjee P., and Neil J.J. Diffusion-tensor MR imaging of normal brain maturation: a guide to structural development and myelination. Am. J. Roentgenol. 180 (2003) 851-859
27. Mukherjee P., Miller J.H., Shimony J.S., Conturo T.E., Lee B.C., Almli C.R., and McKinstry R.C. Normal brain maturation during childhood: developmental trends characterized with diffusion-tensor MR imaging. Radiology 221 (2001) 349-358
28. Mukherjee P., and McKinstry R.C. Diffusion tensor imaging and tractography of human brain development. Neuroimaging Clin. N. Am. 16 (2006) 19-43
29. 18F]FDG microPET and small-animal MRI. Nucl. Med. Biol. 32 (2005) 567-572
30. Lancaster J.L., Glass T.G., Lankipalli B.R., Downs H., Mayberg H., and Fox P.T. A modality-independent approach to spatial normalization of tomographic images of the human brain. Hum. Brain Mapp. 3 (1995) 209-223
31. Ota M., Obata T., Akine Y., Ito H., Ikehira H., Asada T., and Suhara T. Age-related degeneration of corpus callosum measured with diffusion tensor imaging. Neuroimage 31 (2006) 1445-1452
32. Wilde E.A., Chu Z., Bigler E.D., Hunter J.V., Fearing M.A., Hanten G., Newsome M.R., Scheibel R.S., Li X., and Levin H.S. Diffusion tensor imaging in the corpus callosum in children after moderate to severe traumatic brain injury. J. Neurotrauma 23 (2006) 1412-1426
33. Basser P.J., Mattiello J., and LeBihan D. Estimation of the effective self-diffusion tensor from the NMR spin echo. J. Magn. Reson. B 103 (1994) 247-254
34. Basser P.J. Inferring microstructural features and the physiological state of tissues from diffusion-weighted images. NMR Biomed. 8 (1995) 333-344
35. Kennedy K.M., and Raz N. Aging white matter and cognition: differential effects of regional variations in diffusion properties on memory, executive functions, and speed. Neuropsychologia 47 (2009) 916-927
36. Madden D.J., Spaniol J., Costello M.C., Bucur B., White L.E., Cabeza R., Davis S.W., Dennis N.A., Provenzale J.M., and Huettel S.A. Cerebral white matter integrity mediates adult age differences in cognitive performance. J. Cogn. Neurosci. 21 (2009) 289-302
37. Banich M.T., Passarotti A.M., White D.A., Nortz M.J., and Steiner R.D. Interhemispheric interaction during childhood: II. Children with early-treated phenylketonuria. Dev. Neuropsychol. 18 (2000) 53-71
38. Gourevitch M.L., Craft S., Dowton S.B., Ambrose P., and Sparta S. Interhemispheric transfer in children with early-treated phenylketonuria. J. Clin. Exp. Neuropsychol. 16 (1994) 393-404
39. White D.A., Nortz M.J., Mandernach T., Huntington K., and Steiner R.D. Deficits in memory strategy use related to prefrontal dysfunction during early development: evidence from children with phenylketonuria. Neuropsychology 15 (2001) 221-229
40. White D.A., Nortz M.J., Mandernach T., Huntington K., and Steiner R.D. Age-related working memory impairments in children with prefrontal dysfunction associated with phenylketonuria. J. Int. Neuropsychol. Soc. 8 (2002) 1-11